A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
Clinical trial NCT05187832 · RECRUITING
Trial details
- NCT number
- NCT05187832
- Sponsor
- Kind Pharmaceuticals LLC
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-05
- Primary completion
- 2026-11-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.